華檢醫療(01931.HK)與一家體外診斷企業訂立投資合作諒解備忘錄
格隆匯5月29日丨華檢醫療(01931.HK)公吿,於2024年5月29日,公司與一家中國境內的潛在合作伙伴("潛在合作伙伴")就投資合作事宜訂立一份不具法律約束力的諒解備忘錄。
潛在合作伙伴於2011年設立,是一家以化學發光技術和產品為核心的體外診斷企業。潛在合作伙伴建立了基於礆性磷酸酶化學發光技術平台,化學發光試劑檢測功能表包括性激素、腫瘤標誌物、甲狀腺功能激素、腎功能檢測、骨代謝、心肌標誌物、高血壓、肝纖維化、術前八項等多個組套。潛在合作伙伴有多年豐富的研發經驗和持續研發能力。尤其在試劑方面,多年的積累具有一定的比較優勢。
根據建議合作,公司將為潛在合作伙伴提供後續運營資金,根據國家藥監部門的相關規定,公司全資子公司將銷售潛在合作伙伴產品,省去了產品重新註冊審批、適配等種種複雜步驟,利用自身成熟銷售管道優勢,把潛在合作伙伴產品推向市場。
增資完成後,公司將利用公司資金、自有品牌和銷售團隊優勢,支持潛在合作伙伴生物專案產品研發,優化公司產品結構。結合體外診斷(IVD)市場發展趨勢,公司利用自有銷售管道推廣潛在合作伙伴生物產品,力爭迅速拓展商業管道,實現公司業績發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.